SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chonkus Maximus is a community driven & operated fan token, dedicated to Chonkus Maximus the Famous chonky cat from Chania, Crete, Greece. A viral TikTok star, known for lounging by the waterfront. A local landmark with a 5.0 Google Maps rating, drawing tourists for photos and social media fame. He went from neighborhood lounge-lizard to global sensation through social media — TikTok, Instagram and Twitter videos tagged with #chonkusmaximus, receiving hundreds of thousands of views. Someone marked his spot on Google Maps as a “destination” — initially as a joke — but it gained traction and reached a consistent 5‑star rating from visitors who came specifically to meet him. His online appeal has even rivaled famous Cretan landmarks like Samaria Gorge and Balos Lagoon, which typically have slightly lower ratings

Chonkus Maximus

Chonkus Maximus is trending as community members observe its constructive market behavior. Discussions highlight the crypto's stable chart, successful retests of support, and potential for expansion. The increased volume and market sentiment suggest growing confidence in $CHONKUS.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to unusual price action and volatility following a reverse split, drawing comparisons to SMX and sparking significant community discussion around potential short squeezes. The stock's low float and high short interest are key talking points, with many anticipating a substantial move in the coming days. Community members are actively debating potential price targets and strategies, contributing to the stock's heightened visibility.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Token is trending as community members discuss its real-world utility through the Flexa network and potential for growth, while others express frustration over its stagnant price and question management's actions. Bullish investors highlight its growing partnerships and potential for a significant revaluation once the market recognizes its value, contrasting it with hyped projects lacking tangible applications. Concerns remain about low volume and the need for increased awareness and adoption.

Camtek Ltd. engages in the business of developing and manufacturing high-end inspection and metrology equipment for the semiconductor industry. The firm is also involved in inspecting integrated circuits and measuring its features on wafers throughout the production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly. The company was founded on October 21, 1987 and is headquartered in Migdal HaEmek, Israel.

Camtek Ltd

Camtek ($CAMT) is trending due to positive Q3 earnings results, exceeding revenue and EPS expectations, and Q4 guidance that suggests continued growth. Bullish analysts are raising price targets, citing the company's strong position in high-performance computing and advanced packaging, particularly related to AI and chiplet applications. Community members are highlighting the company's consistent profitability and potential for further upside, with some suggesting it could be a beneficiary of increased demand for AI chips and capital expenditures within the semiconductor industry.

The Sandbox is a community-driven platform where creators can monetize voxel ASSETS and gaming experiences on the blockchain.  SAND is the utility token used throughout The Sandbox ecosystem as the basis of transactions and interactions. It is an ERC-20 utility token built on the Ethereum blockchain. There is a finite supply of 3,000,000,000 SAND.

The Sandbox

SAND is trending as community members highlight its potential for a significant run, drawing comparisons to past rallies and noting the accumulation of volume and eyes on the crypto. Bullish sentiment is fueled by factors such as multi-year lows, upcoming potential news catalysts, ties to established brands, and the growing interest in metaverse-related projects. Discussions also mention SAND's market cap and potential for growth within the web3 sector.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Halozyme (HALO) is trending as community members discuss the potential implications of its patent litigation with Merck, particularly following a recent ruling in Germany, and how this could affect future licensing agreements. Bullish investors believe the market is undervaluing HALO, pointing to strong fundamentals and potential catalysts such as new partnership deals and patent extensions, while some traders are eyeing oversold conditions for a possible bullish reversal. The company's ENHANZE technology and royalty revenue potential continue to be key discussion points.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

CVKD is trending as traders discuss recent price movements and bullish technical indicators, with many highlighting its ultra-low float and potential for rapid price swings. Some are pointing to the company's Q3 results and pipeline expansion as potential catalysts. Community members are also closely watching support zones and anticipating further upward momentum.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. ($INOD) is trending due to speculation surrounding a potential partnership with a major defense contractor like Lockheed Martin or Palantir, fueled by comments from Innodata's CEO about a strategically significant relationship. The community speculates this partnership could be a "game changer," conveying market leadership in AI training for military applications and opening doors to sovereign AI projects in nations like Saudi Arabia and the UAE. Discussions also highlight Innodata's existing AI capabilities and the potential financial impact of a substantial partnership.

Codatta

XNY (Codatta) is gaining attention as community members discuss its potential for gains and strong performance against the market, particularly in light of Bitcoin's movements. The coin's chart patterns and recent activity, including a bounce off a support zone, are being watched closely for signs of a breakout and further upward momentum. Some users are also discussing Codatta's fundamentals related to AI/data utility and on-chain fingerprint verification technology.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the community discusses its potential for significant growth and compares its chart to other meme coins. Some investors are expressing optimism, anticipating a substantial rally, while others point to potential catalysts like upcoming marketing announcements and its unique on-chain matrix structure. Discussions also revolve around potential outperformace against other meme coins, and the possibility of integration with Elon Musk's ventures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arbutus Biopharma Corporation $ABUS Shares Purchased by Two Seas Capital LP

Two Seas Capital LP increased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 10.3% during the 2nd quarter, according to its most recent Form 13F filing with...

Arbutus Biopharma (NASDAQ:ABUS) Given Buy Rating at Chardan Capital

Chardan Capital reiterated a "buy" rating and issued a $5.00 price target on shares of Arbutus Biopharma in a research report on Friday...

Arbutus Biopharma (NASDAQ:ABUS) Downgraded by Wall Street Zen to Hold

Wall Street Zen cut Arbutus Biopharma from a "buy" rating to a "hold" rating in a research report on Saturday...

Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.04) EPS for the quarter, topping analysts' consensus...

Are Medical Stocks Lagging  Arbutus Biopharma (ABUS) This Year?

Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?

Here is how Novartis (NVS) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?

Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

Here is how Aquestive Therapeutics (AQST) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$4.42
Prev Close	$4.41
Open	$4.43
Dividend Yield	0.00%
50-Day Moving Average	$4.44
Beta	0.93
Avg. Volume	1.06M
PE Ratio	-19.93

52-Week High	$5.10
52-Week Low	$2.71
Market Capitalization	$850.07M
EPS (Annual)	-$0.3767
Price to Book	10.96
Revenue Per Employee	$140,250.00
Enterprise Value/EBITDA	N/A

ABUS
Arbutus Biopharma Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABUS News

ABUSArbutus Biopharma Corp